Tolerability and Acceptance of Prolonged Low/Delayed Mitoxantrone Regimens in Patients with Worsening Multiple Sclerosis

Publisher： Karger

E-ISSN： 1421-9913|65|1|40-45

ISSN： 0014-3022

Source： European Neurology, Vol.65, Iss.1, 2010-12, pp. : 40-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessment of Potential Cardiotoxic Side Effects of Mitoxantrone in Patients with Multiple Sclerosis

By  

European Neurology, Vol. 54, Iss. 1, 2005-09 ,pp. : 28-33

Karger

Access to resources Recommend Favorite

Effects of Mitoxantrone on Multiple Sclerosis Patients’ Lymphocyte Subpopulations and Production of Immunoglobulin, TNF-alpha and IL-10

By  

European Neurology, Vol. 49, Iss. 3, 2003-03 ,pp. : 137-141

Karger

Access to resources Recommend Favorite

Mitoxantrone Does Not Restore the Impaired Suppressive Function of Natural Regulatory T Cells in Patients Suffering from Multiple Sclerosis

By  

European Neurology, Vol. 61, Iss. 1, 2008-10 ,pp. : 27-32

Karger

Access to resources Recommend Favorite

Escalating Immunotherapy with Mitoxantrone in Patients with Very Active Relapsing-Remitting or Progressive Multiple Sclerosis

By  

European Neurology, Vol. 43, Iss. 3, 2000-04 ,pp. : 186-187

Karger

Access to resources Recommend Favorite

Long-Term Risk of Leukaemia or Cardiomyopathy after Mitoxantrone Therapy for Multiple Sclerosis

By  

European Neurology, Vol. 67, Iss. 1, 2011-12 ,pp. : 45-47

Karger

Access to resources Recommend Favorite